Valuation Moves Across Major Stocks
April 5, 2026 at 23:10 UTC

Key Points
- New DCF work flags Procter & Gamble (PG) as undervalued despite recent share price pressure
- Narrative valuations highlight Griffon and VICI Properties as trading below fair value estimates
- Intercontinental Exchange’s US$2 billion Polymarket deal underpins a higher data driven fair value view
- High P/E multiples at Intuitive Surgical (ISRG) and Pony AI contrast with models that see upside
Fresh Valuation Checks Across Key Names
A series of new analyses from Simply Wall St on April 5, 2026, highlight how valuation signals have shifted for several widely followed companies. Across sectors from consumer staples and real estate to industrials and autonomous driving, discounted cash flow work, P/E comparisons and narrative-based models are being used to frame whether recent share price moves leave room for upside or point to elevated risk.
Procter & Gamble: Product Refresh and Valuation Gap
Procter & Gamble (PG) is trading around US$143 per share, with Simply Wall St’s DCF framework indicating a fair value of about US$204, implying the stock is roughly 29.8% below that estimate. The model uses a two stage free cash flow to equity approach, with latest 12 month free cash flow of about US$15.4 billion and projected free cash flow rising to US$23.1 billion by 2035.
On an earnings basis, Procter & Gamble (PG) trades at a P/E of 20.58x, below a calculated “Fair Ratio” of 23.89x, again pointing to undervaluation in that framework. Community narratives span a bullish fair value of US$150 per share and a cautious view near US$121, illustrating the range of assumptions investors are applying to growth, margins and risk.
Operationally, the company is testing consumer behaviour shifts through Dawn’s new refill jug and upgraded Platinum dish soap formula. The initiative focuses on convenience and waste reduction, aiming to entrench refill routines in a low priced, high frequency category. These changes sit against a mixed share performance that includes a 10.2% decline over the past year but a 19.1% gain over five years.
Undervalued Signals at Griffon, VICI, IDEX and AIT
Griffon shares recently closed at US$71.42, which one popular narrative views as 37.4% below a fair value of US$114.14 per share. That upside case rests on margin expansion from an asset light sourcing model and cost optimisation in Consumer and Professional Products, but stands alongside near term pressure from weaker demand and elevated inventories.
VICI Properties, at about US$27.66, is assessed as 47.9% below a DCF derived intrinsic value of roughly US$53.11 per share based on projected adjusted funds from operations. Its P/E of 10.65x sits below both sector averages and a Fair Ratio of 31.10x, and the stock scores 6 out of 6 on the platform’s valuation checks, though recent returns have been mixed.
Industrial names show similar gaps. IDEX closed at US$190.47 against a narrative fair value of US$224.29 and a DCF value of US$252.21, while Applied Industrial Technologies trades at US$267.12 versus a narrative fair value of US$309.17 and analyst targets of US$305. In both cases, narrative work highlights earnings and margin expansion, yet current P/E multiples sit above sector averages and Fair Ratios, signalling valuation tension.
Data and Growth Stories: ICE, Intuitive Surgical, Pony AI and Kering
Intercontinental Exchange has completed a US$2.0 billion multi stage investment in Polymarket, including US$600 million of new cash and plans to buy up to US$40 million of existing securities, and secured exclusive global rights to distribute Polymarket’s event driven data. A community narrative projects ICE reaching US$12.0 billion in revenue and US$4.3 billion in earnings by 2029, implying a fair value of US$197.21, about 21% above its current price.
In healthcare, Intuitive Surgical’s (ISRG) DCF based intrinsic value of US$369.32 per share compares with a market price near US$452, suggesting 22.4% overvaluation on that measure. Its P/E of 56.22x stands above industry and peer averages and a Fair Ratio of 35.13x, while community narratives span fair values from about US$325.55 to US$532.46 depending on growth and margin assumptions.
Pony AI trades near US$9.22 after sharp 30 and 90 day declines, but a widely followed narrative assigns a US$15.00 fair value, 38.5% above the latest close and below a higher analyst consensus target. That view leans on rapid revenue expansion and margin repair, even as a current P/S of 44.4x far exceeds industry and peer benchmarks and a Fair Ratio of 9.1x. In luxury, Kering’s (KERp) recent rebound leaves the shares around €265.25 versus a narrative fair value of €294.54, or 9.9% implied undervaluation, tied to brand turnaround and margin repair efforts at Gucci and other labels.
Key Takeaways
- Recent Simply Wall St work shows many stocks trading below narrative or DCF fair values, but with notable variation by sector and metric
- Consumer, industrial and REIT names such as Procter & Gamble, IDEX, Applied Industrial Technologies and VICI screen as undervalued on cash flow and narrative models
- High growth and technology driven stories including Intuitive Surgical (ISRG) and Pony AI exhibit valuation tension, with rich multiples offsetting some model based upside
- Narrative based valuations, Fair Ratios and traditional DCF or P/E checks often send different signals, underscoring the importance of understanding the assumptions behind each approach
References
- 1. https://finance.yahoo.com/markets/stocks/articles/procter-gamble-pg-pricing-reflect-220845265.html
- 2. https://finance.yahoo.com/markets/stocks/articles/kering-enxtpa-ker-valuation-check-220834274.html
- 3. https://finance.yahoo.com/markets/stocks/articles/look-griffon-gff-valuation-analyst-220734316.html
- 4. https://finance.yahoo.com/markets/stocks/articles/too-consider-intuitive-surgical-isrg-210755002.html
Get premium market insights delivered directly to your inbox.